YMAB

Y-mAbs Therapeutics
YMAB

Overview Fund Activity
Delisted

YMAB was delisted on the 15th of September, 2025.

Back to rankings

37 hedge funds and large institutions have $205M invested in Y-mAbs Therapeutics in 2018 Q3 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+37
Holders Change %
–
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
37
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SI
Sofinnova Investments
California
+$55.9M
2
SCM
Scopia Capital Management
New York
+$42.2M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$32.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$10.3M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$8.63M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
TAM
26
Tiverton Asset Management
Delaware
$348K +$348K +13,080 New
GCP
27
GSA Capital Partners
United Kingdom
$266K +$266K +10,000 New
FCM
28
Flinton Capital Management
Pennsylvania
$236K +$236K +8,874 New
TAM
29
Tyers Asset Management
Texas
$194K +$194K +7,308 New
NA
30
Neuburgh Advisers
California
$153K +$153K +5,742 New
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$133K +$133K +5,000 New
MCIM
32
Meadow Creek Investment Management
Georgia
$111K +$111K +4,176 New
PHK
33
Point72 Hong Kong
Hong Kong
$86K +$86K +3,252 New
RCM
34
Riverhead Capital Management
Delaware
$63K +$63K +2,380 New
CSS
35
Cubist Systematic Strategies
Connecticut
$55K +$55K +2,082 New
CCA
36
Catalyst Capital Advisors
New York
$13K +$13K +500 New
Bank of America
37
Bank of America
North Carolina
$5K +$5K +191 New
Morgan Stanley
38
Morgan Stanley
New York
$3K +$3K +100 New
1
2